title: Dual antiplatelet therapy after acute coronary syndrome: a cardiologist-based optimal decision.
authors.affiliation: Service de Cardiologie, Pôle Cœur Thorax Vasculaire, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours, France.
authors.forename: Denis
authors.initials: D
authors.lastname: Angoulvant
authors.affiliation: Service de Pharmacologie clinique, Centre Hospitalier Universitaire Bretonneau et Faculté de Médecine, Université François Rabelais, Tours, France.
authors.forename: Theodora Bejan
authors.initials: TB
authors.lastname: Angoulvant
authors.affiliation: Service de Cardiologie, Pôle Cœur Thorax Vasculaire, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Fauchier
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D010879:Piperazines / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D058921:Purinergic P2Y Receptor Antagonists / Q000009:adverse effects*; D013876:Thiophenes / Q000009:adverse effects*; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D013988:Ticlopidine